Biotechnology Companies' Annual Reports & Investor Relations Material

582 Companies

NRI

Nuvo Pharmaceuticals, Inc.

Nuvo Pharmaceuticals is a healthcare company with a diverse product portfolio and a global reach, with a particular focus on the Canadian market. The company specializes in therapeutic areas such a...

Nuvo Pharmaceuticals, Inc. Annual Report 2020

Healthcare Biotechnology TSX 51-200

AGTC

Applied Genetic

Applied Genetic Technologies Corporation is a biotechnology company specializing in gene therapy products for inherited orphan ophthalmology diseases in the United States. The company's lead produc...

Applied Genetic Annual Report 2021

Healthcare Biotechnology NASDAQ 51-200

NXS

Next Science Limited

Next Science Limited is a medical technology company that focuses on eradicating health issues caused by biofilms. Their products, developed using their Xbio Technology platform, include antimicrob...

Next Science Limited Annual Report 2023

Healthcare Biotechnology ASX 11-50

ITRM

Iterum Therapeutics plc

Dublin-based pharmaceutical company Iterum Therapeutics plc is making strides in the field of anti-infectives. The clinical-stage firm operates in Ireland, Bermuda, and the US, with a particular fo...

Iterum Therapeutics plc Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

BDTX

Black Diamond Therapeutics, Inc.

Cambridge-based Black Diamond Therapeutics, a clinical-stage company specializing in precision oncology medicine, is dedicated to discovering and developing therapies for patients suffering from ge...

Black Diamond Therapeutics, Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 11-50

CCXI

ChemoCentryx Inc

ChemoCentryx is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing orally administered therapeutics for autoimmune diseases, inflammatory disorders...

ChemoCentryx Inc Annual Report 2020

Healthcare Biotechnology NASDAQ 51-200

TLX

Talanx

Telix Pharmaceuticals Limited is a radiopharmaceutical company that develops molecularly targeted radiation products for cancer care. The company is focused on developing diagnostic and therapeutic...

Talanx Annual Report 2023

Healthcare Biotechnology ASX 51-200

MNTA

Momenta Pharmaceuticals Inc.

Momenta Pharmaceuticals is a company that focuses on biotechnology and specializes in characterizing and engineering complex molecules. The company is based in Cambridge, Massachusetts and has been...

Momenta Pharmaceuticals Inc. Annual Report 2018

Healthcare Biotechnology NASDAQ 201-500

FOMX

Foamix Pharmaceuticals Ltd

Foamix Pharmaceuticals Ltd. is a specialty pharmaceutical company that focuses on developing and selling foam-based products for the treatment of various skin conditions, including acne and impetig...

Foamix Pharmaceuticals Ltd Annual Report 2017

Healthcare Biotechnology NASDAQ 11-50

INSY

Insys Therapeutics Inc

Insys Therapeutics is a specialty pharmaceutical company with a focus on supportive care products. The opioid-tolerant cancer patients market Subsys, a fentanyl spray for breakthrough cancer pain, ...

Insys Therapeutics Inc Annual Report 2017

Healthcare Biotechnology NASDAQ 201-500

GALT

Galectin Therapeutics Inc.

Galectin Therapeutics Inc., a biopharmaceutical company at the clinical stage, is making strides in developing therapies for a variety of diseases, including cancer and fibrotic conditions. Among i...

Galectin Therapeutics Inc. Annual Report 2023

Healthcare Biotechnology NASDAQ 1-10

OVB

Ovoca Bio

Ovoca Bio is a biopharmaceutical company that specializes in women's health, particularly in the development of a novel treatment for women with hypoactive sexual desire disorder (HSDD). This condi...

Ovoca Bio Annual Report 2023

Healthcare Biotechnology LSE 1-10

PRTC

PureTech Health

Boston-based PureTech Health plc is a biotherapeutics company that is focused on discovering, developing and commercializing medicines aimed at treating a number of diseases including inflammatory,...

PureTech Health Annual Report 2023

Healthcare Biotechnology LSE 51-200

FULC

Fulcrum Therapeutics Inc

Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company that specializes in developing products for genetically defined diseases with high unmet medical needs, is making strides in t...

Fulcrum Therapeutics Inc Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200

SLDB

Solid Biosciences

Solid Biosciences Inc., a life science company based in Charlestown, Massachusetts, is making strides in the development of therapies for neuromuscular and cardiac diseases in the United States. At...

Solid Biosciences Annual Report 2023

Healthcare Biotechnology NASDAQ 51-200